104 related articles for article (PubMed ID: 2407334)
1. An immunohistochemical analysis of ras oncogene expression in epithelial neoplasms of the colon.
Jansson DS; Radosevich JA; Carney WP; Rosen ST; Schlom J; Staren ED; Hyser MJ; Gould VE
Cancer; 1990 Mar; 65(6):1329-37. PubMed ID: 2407334
[TBL] [Abstract][Full Text] [Related]
2. ras p21 oncoprotein expression in human colonic neoplasia--an immunohistochemical study with monoclonal antibody RAP-5.
Lanza G
Histopathology; 1988 Jun; 12(6):595-609. PubMed ID: 3047043
[TBL] [Abstract][Full Text] [Related]
3. Ras oncogene p21 levels parallel malignant potential of different human colonic benign conditions.
Michelassi F; Leuthner S; Lubienski M; Bostwick D; Rodgers J; Handcock M; Block GE
Arch Surg; 1987 Dec; 122(12):1414-6. PubMed ID: 3318757
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical detection of the ras oncogene p21 product in an experimental tumour and in human colorectal neoplasms.
Williams AR; Piris J; Spandidos DA; Wyllie AH
Br J Cancer; 1985 Nov; 52(5):687-93. PubMed ID: 3904801
[TBL] [Abstract][Full Text] [Related]
5. Enhanced expression of c-Ha-ras p21 in human stomach adenocarcinomas defined by immunoassays using monoclonal antibodies and in situ hybridization.
Ohuchi N; Hand PH; Merlo G; Fujita J; Mariani-Costantini R; Thor A; Nose M; Callahan R; Schlom J
Cancer Res; 1987 Mar; 47(5):1413-20. PubMed ID: 2434216
[TBL] [Abstract][Full Text] [Related]
6. Expression of the nuclear oncogene p53 in colon tumours.
van den Berg FM; Tigges AJ; Schipper ME; den Hartog-Jager FC; Kroes WG; Walboomers JM
J Pathol; 1989 Mar; 157(3):193-9. PubMed ID: 2926561
[TBL] [Abstract][Full Text] [Related]
7. Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas.
Krajewska M; Moss SF; Krajewski S; Song K; Holt PR; Reed JC
Cancer Res; 1996 May; 56(10):2422-7. PubMed ID: 8625322
[TBL] [Abstract][Full Text] [Related]
8. 32/67-kD laminin receptor expression in human colonic neoplasia: elevated transcript levels correlate with the degree of epithelial dysplasia.
Stallmach A; Orzechowski HD; Feldmann P; Riecken EO; Zeitz M; Herbst H
Am J Gastroenterol; 1999 Nov; 94(11):3341-7. PubMed ID: 10566741
[TBL] [Abstract][Full Text] [Related]
9. [Expression of ras oncogene product P21 in thyroid tumors: an immunohistochemical study].
Gui K
Zhonghua Yi Xue Za Zhi; 1990 Mar; 70(3):140-2, 12. PubMed ID: 2163739
[TBL] [Abstract][Full Text] [Related]
10. Histologic demonstration of antigens reactive with anti-p21 ras monoclonal antibody (RAP-5) in human stomach cancers.
Noguchi M; Hirohashi S; Shimosato Y; Thor A; Schlom J; Tsunokawa Y; Terada M; Sugimura T
J Natl Cancer Inst; 1986 Aug; 77(2):379-85. PubMed ID: 3525957
[TBL] [Abstract][Full Text] [Related]
11. Quantitation of Harvey ras p21 enhanced expression in human breast and colon carcinomas.
Hand PH; Vilasi V; Thor A; Ohuchi N; Schlom J
J Natl Cancer Inst; 1987 Jul; 79(1):59-65. PubMed ID: 3298786
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical localization of the epithelial marker MAM-6 in invasive malignancies and highly dysplastic adenomas of the large intestine.
Zotter S; Lossnitzer A; Hageman PC; Delemarre JF; Hilkens J; Hilgers J
Lab Invest; 1987 Aug; 57(2):193-9. PubMed ID: 3613527
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical expression of fatty acid synthase, apoptotic-regulating genes, proliferating factors, and ras protein product in colorectal adenomas, carcinomas, and adjacent nonneoplastic mucosa.
Visca P; Alò PL; Del Nonno F; Botti C; Trombetta G; Marandino F; Filippi S; Di Tondo U; Donnorso RP
Clin Cancer Res; 1999 Dec; 5(12):4111-8. PubMed ID: 10632348
[TBL] [Abstract][Full Text] [Related]
14. [Immunohistochemical studies of ras oncogene product p21 in human ovarian tumors].
Yaginuma Y; Yamashita K
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Sep; 41(9):1409-16. PubMed ID: 2685141
[TBL] [Abstract][Full Text] [Related]
15. Expression of a new mucin-type glycoprotein in select epithelial dysplasias and neoplasms detected immunocytochemically with Mab A-80.
Shin SS; Gould VE; Gould JE; Warren WH; Gould KA; Yaremko ML; Manderino GL; Rittenhouse HG; Tomita JT; Jansson DS
APMIS; 1989 Dec; 97(12):1053-67. PubMed ID: 2611021
[TBL] [Abstract][Full Text] [Related]
16. Activation of the ras genes in malignant and premalignant colorectal tumors.
Glarakis IS; Savva S; Spandidos DA
Oncol Rep; 1998; 5(6):1451-4. PubMed ID: 9769386
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibodies define differential ras gene expression in malignant and benign colonic diseases.
Thor A; Horan Hand P; Wunderlich D; Caruso A; Muraro R; Schlom J
Nature; 1984 Oct 11-17; 311(5986):562-5. PubMed ID: 6482968
[TBL] [Abstract][Full Text] [Related]
18. [Detection of Ki-ras oncogene mutations in normal mucosa, adenoma and adenocarcinoma of the colon].
Wang ZY
Zhonghua Bing Li Xue Za Zhi; 1993 Dec; 22(6):333-6. PubMed ID: 7913419
[TBL] [Abstract][Full Text] [Related]
19. Paneth cell differentiation in colonic epithelial neoplasms: evidence for the role of the Apc/beta-catenin/Tcf pathway.
Joo M; Shahsafaei A; Odze RD
Hum Pathol; 2009 Jun; 40(6):872-80. PubMed ID: 19269007
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical study of oncogene product ras p21, c-myc and growth factor EGF in breast carcinomas.
Mizukami Y; Nonomura A; Noguchi M; Taniya T; Koyasaki N; Saito Y; Hashimoto T; Matsubara F; Yanaihara N
Anticancer Res; 1991; 11(4):1485-94. PubMed ID: 1660689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
